Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)

NCT04954859 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

DRUG: Bepirovirsen
DRUG: Placebo

Sponsor

GlaxoSmithKline